Insulin Sensitivity and Secretion in Obese Type 2 Diabetic Women after Various Bariatric Operations
Jazyk angličtina Země Švýcarsko Médium print-electronic
Typ dokumentu klinické zkoušky, časopisecké články
PubMed
27951535
PubMed Central
PMC5644812
DOI
10.1159/000453000
PII: 000453000
Knihovny.cz E-zdroje
- MeSH
- bariatrická chirurgie metody MeSH
- beta-buňky fyziologie MeSH
- biliopankreatická diverze metody MeSH
- diabetes mellitus 2. typu komplikace metabolismus chirurgie MeSH
- dospělí MeSH
- inzulin metabolismus MeSH
- inzulinová rezistence * MeSH
- krevní glukóza metabolismus MeSH
- laparoskopie metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- morbidní obezita komplikace metabolismus chirurgie MeSH
- sekrece inzulinu MeSH
- senioři MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- Názvy látek
- inzulin MeSH
- krevní glukóza MeSH
OBJECTIVE: To compare the effects of biliopancreatic diversion (BPD) and laparoscopic gastric banding (LAGB) on insulin sensitivity and secretion with the effects of laparoscopic gastric plication (P). METHODS: A total of 52 obese women (age 30-66 years) suffering from type 2 diabetes mellitus (T2DM) were prospectively recruited into three study groups: 16 BPD; 16 LAGB, and 20 P. Euglycemic clamps and mixed meal tolerance tests were performed before, at 1 month and at 6 months after bariatric surgery. Beta cell function derived from the meal test parameters was evaluated using mathematical modeling. RESULTS: Glucose disposal per kilogram of fat free mass (a marker of peripheral insulin sensitivity) increased significantly in all groups, especially after 1 month. Basal insulin secretion decreased significantly after all three types of operations, with the most marked decrease after BPD compared with P and LAGB. Total insulin secretion decreased significantly only following the BPD. Beta cell glucose sensitivity did not change significantly post-surgery in any of the study groups. CONCLUSION: We documented similar improvement in insulin sensitivity in obese T2DM women after all three study operations during the 6-month postoperative follow-up. Notably, only BPD led to decreased demand on beta cells (decreased integrated insulin secretion), but without increasing the beta cell glucose sensitivity.
Zobrazit více v PubMed
Fried M. Bariatric and metabolic surgery. Minerva Endocrinol. 2013;38:237–244. PubMed
Tham JC, Howes N, le Roux CW. The role of bariatric surgery in the treatment of diabetes. Ther Adv Chronic Dis. 2015;5:149–157. PubMed PMC
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–256. e5. PubMed
Knop FK, Taylor R. Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care. 2013;36((suppl 2)):S287–291. PubMed PMC
Lee WJ, Almulaifi A. Recent advances in bariatric/metabolic surgery: appraisal of clinical evidence. J Biomed Res. 2015;29:98–104. PubMed PMC
Bradnova O, Kyrou I, Hainer V, Vcelak J, Halkova T, Sramkova P, Dolezalova K, Fried M, McTernan P, Kumar S, Hill M, Kunesova M, Bendlova B, Vrbikova J. Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones. Obes Surg. 2014;24:718–726. PubMed
Fried M, Dolezalova K, Sramkova P. Adjustable gastric banding outcomes with and without gastrogastric imbrication sutures: a randomized controlled trial. Surg Obes Relat Dis. 2011;7:23–31. PubMed
Talebpour M, Talebpour A, Barzin G, Shariat Moharari R, Khajavi MR . Effects of laparoscopic gastric plication (LGP) in patients with type 2 diabetes, one year follow-up. J Diabetes Metab Disord. 2015;14:60. PubMed PMC
Brethauer SA, Harris JL, Kroh M, Schauer PR. Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis. 2011;7:15–22. PubMed
Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M, Briatore L, D'Alessandro G, Andraghetti G, Cordera R. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2014;253:699–703. PubMed
Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres AJ, Weiner R, Yashkov Y, Fruhbeck G. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts. 2013;6:449–468. PubMed PMC
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:e214–223. PubMed
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–429. PubMed
Mari A, Camastra S, Toschi E, Giancaterini A, Gastaldelli A, Mingrone G, Ferrannini E. A model for glucose control of insulin secretion during 24 h of free living. Diabetes. 2001;50((suppl 1)):S164–168. PubMed
Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41:368–377. PubMed
Meloun M, Hill M, Militky J, Kupka K. Transformation in the PC-aided biochemical data analysis. Clin Chem Lab Med. 2000;38:553–559. PubMed
Meloun M, Militky J, Hill M, Brereton RG. Crucial problems in regression modelling and their solutions. Analyst. 2002;127:433–450. PubMed
Panunzi S, De Gaetano A, Carnicelli A, Mingrone G. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg. 2015;261:459–467. PubMed
Verdi D, Prevedello L, Albanese A, Lobba A, Foletto M. Laparoscopic gastric plication (LGCP) vs sleeve gastrectomy (LSG): a single institution experience. Obes Surg. 2015;25:1653–1657. PubMed
Robert M, Ferrand-Gaillard C, Disse E, Espalieu P, Simon C, Laville M, Gouillat C, Thivolet C. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013;23:770–775. PubMed
Kunešová M, Sedláčková B, Bradnová O, Tvrzická E, Staňková B, Šrámková P, DoleŽalová K, Kalousková P, Hlavatý P, Hill M, Bendlová B, Fried M, Hainer V, Vrbíková J. Fatty acid composition of adipose tissue triglycerides in obese diabetic women after bariatric surgery: a 2-year follow up. Physiol Res. 2015;64((suppl 2)):S155–166. PubMed
Yska JP, van Roon EN, de Boer A, Leufkens HG, Wilffert B, de Heide LJ, de Vries F, Lalmohamed A. Remission of type 2 diabetes mellitus in patients after different types of bariatric surgery: a population-based cohort study in the United Kingdom. JAMA Surg. 2015;150:1126–1133. PubMed
Malkani S. An update on the role of bariatric surgery in diabetes management. Curr Opin Endocrinol Diabetes Obes. 2015;22:98–105. PubMed
Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes − 3-year outcomes. N Engl J Med. 2014;370:2002–2013. PubMed PMC
Mingrone G, Castagneto M. Bariatric surgery: unstressing or boosting the beta-cell? Diabetes Obes Metab. 2009;11:130–142. PubMed
Alam I, Stephens JW, Fielding A, Lewis KE, Lewis MJ, Baxter JN. Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2012;8:752–763. PubMed
Tsoli M, Chronaiou A, Kehagias I, Kalfarentzos F, Alexandrides TK. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis. 2013;9:667–677. PubMed
Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M, Mingrone G. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025–2031. PubMed
Astiarraga B, Gastaldelli A, Muscelli E, Baldi S, Camastra S, Mari A, Papadia F, Camerini G, Adami G, Scopinaro N, Ferrannini E. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab. 2013;98:2765–2773. PubMed
Dutia R, Brakoniecki K, Bunker P, Paultre F, Homel P, Carpentier AC, McGinty J, Laferrere B. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 2014;63:1214–1223. PubMed PMC
Pontiroli AE. Comment on Dutia et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 2014;63:1214–1223. Diabetes 2014;63:e3. PubMed PMC
World Medical Association Declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277:925–926. PubMed